share_log

Takeda Pharmaceutical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(4.96%),Takeda Ventures, Inc(4.96%)

武田制药 | SC 13G/A:超过5%持股股东披露文件(修正)-Takeda Pharmaceutical Company Limited(4.96%),Takeda Ventures, Inc(4.96%)

美股sec公告 ·  2022/08/04 19:59
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息